Skip to main content
Signal8

Cockroft Bettina M.

SEC insider (Form 3/4/5 filer). CIK 0001900452. Director at Annexon, Inc. (ANNX) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in BRISBANE, CA.

Companies Cockroft Bettina M. has filed insider reports for

  • Annexon, Inc. (ANNX): Director
  • CNS Pharmaceuticals, Inc. (CNSP): Director
Cockroft Bettina M. profile photo

Cockroft Bettina M.

CIK: 0001900452

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Annexon, Inc. logo
ANNX

Annexon, Inc.

Director
CNS Pharmaceuticals, Inc. logo
CNSP

CNS Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Annexon, Inc. logo
    ANNX

    Annexon, Inc.

    Jun 11, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    65K shares-
  • CNS Pharmaceuticals, Inc. logo
    CNSP

    CNS Pharmaceuticals, Inc.

    Nov 17, 2025
    Award

    Option to purchase common stock

    Direct
    1.5K shares-
  • Annexon, Inc. logo
    ANNX

    Annexon, Inc.

    Jun 5, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    55K shares-

1-3 of 3